Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69097-967

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69097-967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Label for Sevelamer Carbonate Tablets 800 mg film coated, containing 270 tablets. The label shows the NDC number 69097-967-93 and indicates prescription use only. It includes inactive ingredient information, storage instructions, and manufacturer details for Cipla USA Inc., Hauppauge, NY. The label contains a barcode and QR code on the right side.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical structure diagram of the active ingredient sevelamer carbonate, showing the polymeric backbone with ammonium and carbonate groups and associated functional moieties.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

A forest plot chart illustrating subgroup analyses for Sevelamer carbonate versus placebo. It presents mean differences with 95% confidence intervals across various subgroups, including screening body surface area (BSA), baseline serum phosphorus, age, and dialysis status, showing the number of patients and statistical data for each subgroup.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

A line chart comparing the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL) between Sevelamer Hydrochloride and an active control. The x-axis shows reduction in serum phosphorus, ranging from worsened increase to improved reduction, and the y-axis shows the percentage of patients with at least that reduction.*

FDA Label Image

Sevelamer Carbonate Tabs Fig04

A line graph showing phosphorus change from baseline over 52 study weeks. It compares two treatments: Sevelamer Hydrochloride and Active-Control, with phosphorus change on the vertical axis and study weeks on the horizontal axis, indicating trends for both groups over time.*

FDA Label Image

Sevelamer Carbonate Tabs Fig05

Label for Sevelamer Carbonate tablets, 800 mg strength, oral film-coated tablets. The label states that the package contains 270 tablets and lists Cipla as the labeler, manufactured by Cipla Ltd., Kurkumbh, India. The label includes dosage instructions, inactive ingredients, storage information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.